Clinical Trials Browser

Phase 2 × Sarcoma × Bortezomib × Clear all

NCT00937495 2014-05-14

Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue Sarcoma

Phase 2 Completed

16 enrolled 6 charts

Sarcoma

NCT00027716 2013-06-06

Bortezomib in Treating Patients With Advanced or Metastatic Sarcoma

Phase 2 Completed

Rhabdomyosarcoma, Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral